Scarica l'app Stockscreener
197.55
1.22%
2.24
Ishares Biotechnology Etf Borsa (IBB) Ultime notizie
Cramer’s mad dash: iShares Biotechnology ETF - MSN
Cramer’s Mad Dash: iShares Biotechnology ETF - CNBC
Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up? - The Motley Fool
IBBiShares Biotechnology ETF Dividends - Finviz
RXRX rallies past biotech ETFs as short interest, insider-sale filings shape coming week - TechStock²
SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns - The Motley Fool
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
Healthcare Stocks Got A Late Lift From Big Headlines - Finimize
Greece’s Return and a Chip Meltdown: MSCI World ETF Caught Between Index History and Market Chaos - Ad-hoc-news.de
How Ishares Biotechnology Etf (IBB) Affects Rotational Strategy Timing - Stock Traders Daily
The biotech sector looks ready for a multi-year breakout: Here's what to watch - MSN
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. - MarketBeat
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A - ETF Database
Biotech's Silent Resurgence (5-Year Base Breakout) - TradingView
Biotech breakout: iShares Biotechnology ETF hits all-time high - Seeking Alpha
Why Is Natera Stock Gaining Tuesday? - Benzinga
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead? - TradingView
Biotech ETF hits record as AbbVie seals $10.9B Apogee deal - MSN
Sector Update: Healthcare - Moomoo
As AbbVie eyes Apogee, these biotech stocks earn the highest Quant ratings (IBB:NASDAQ) - Seeking Alpha
DFTX Stock Rallies Ahead Of High-Stakes Phase 3 Depression Drug Trial Results — What Investors Need To Know - TradingView
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
Syntax Bio expands Series A to $14.4M, adds leadership and board members (IBB:NASDAQ) - Seeking Alpha
2Seventy Bio Inc (TSVT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CARGO Therapeutics Inc (CRGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CureVac NV (CVAC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? - The Motley Fool
Anavex Life Sciences Corp (AVXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iShares NASDAQ Biotechnology ETF declares quarterly distribution of $0.0238 - MSN
Tevogen Bio Holdings Inc (TVGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inozyme Pharma Inc (INZY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Altimmune Inc (ALT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nautilus Biotechnology Inc (NAUT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arrivent Biopharma Inc (AVBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
IShares TrustiShares Biotechnology ETF announces Quarterly dividend, payable on June 18, 2026 - marketscreener.com
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - TradingView
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance
IBBm Holdings (iShares Biotechnology Cedear) - Investing.com
Sector Update: Healthcare Stocks Gain Friday Afternoon - Moomoo
BioCardia Jumps After FDA Feedback Seen Positive for CardiAMP Approval - TechStock²
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Friday After May Jobs Report - Moomoo
Flow Focus | Marvell Ripped, Broadcom Cracked — AI Money Is Getting Pickier - Moomoo
Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows - Benzinga
Recursion Stock Jumps Before Goldman Sachs Event as AI-Drug Trade Gets Fresh Heat - TechStock²
Alnylam Eyes Faster Drug Discovery With AI Partnership Worth Up To $2 Billion - Benzinga
Sector Update: Healthcare Stocks Rise Premarket Thursday - Moomoo
Tectonic Therapeutic Stock Climbs as Broader Market Sinks - Bez Kabli
Kyverna Therapeutics Stock Barely Moves—The Bigger CAR-T Test Is Coming - Bez Kabli
MacroGenics Shares Pop on 2028 Cash Runway Focus - Bez Kabli
Chemomab Drops After Board Changes and CEO Stock Purchase - Bez Kabli
DiaMedica Shares Down Ahead of Stroke Trial Update - Bez Kabli
Aura Biosciences Stock Falls After Eye-Cancer Trial News - Bez Kabli
5 Biggest Biotechnology ETFs in 2026 - Investing News Network
Hot Money Rotates to Keep the Market Running - TheStreet Pro
Design Therapeutics Drops Ahead of Jefferies, Trial Remains in Focus for DSGN - Bez Kabli
Ligand Shares Hold Up in Biotech Rout While XOMA Deal Heads for Investor Vote - Bez Kabli
Legend Biotech Stock Jumps on Full Response in Small Trial as Traders React Quickly - TechStock²
VivoSim Stock Sits Near 52-Week Low, Biotech Faces Pre-Market Cash Crunch - Bez Kabli
Healthcare Stocks Slipped As Biotech Took A Beating - Finimize
Healthcare Stocks Slipped As A Cancer Screening Trial Disappointed - Finimize
Celcuity Rises Ahead of ASCO Update With FDA Deadline Pressing - Bez Kabli
Zai Lab Shares Slide 4.27% as Biotech Sector Faces HeadwindsLow Risk Entry Stocks - thelegaladvocate.com
Orchestra BioMed Shares Trade Lower Ahead of Trial Milestone - Bez Kabli
Vaxcyte Inc. (PCVX) Slips 1.4% as Shares Test Key Support ZoneAdaptive Moving Average - thelegaladvocate.com
Daily ETF Flows: NVDL In Demand - ETF.com
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
iShares Biotechnology ETF (IBB) Latest Announcement & Press Release - Moomoo
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):